THERAPEUTIC OPTIONS IN ENDOMETRIOSIS: A COMPARATIVE LITERATURE REVIEW OF INTRAUTERINE DEVICE THERAPY, SURGICAL TREATMENT, RELUGOLIX COMBINATION THERAPY, AND DIENOGEST
Authors:
- Katarzyna ŚcibiszKŚKatarzyna Ścibisz
- Karolina OllikKOKarolina Ollik
- Kamil HarenzaKHKamil Harenza
- Mateusz TaranowiczMTMateusz Taranowicz
- Olga KowalczykOKOlga Kowalczyk
- Dominika ZdobylakDZDominika Zdobylak
- Monika KowalskaMKMonika Kowalska
- Anita ZięBaAZAnita ZięBa
- Michał DominMDMichał Domin
- Justyna CałkaJCJustyna Całka
Open Access
- 2 March 2026
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
Abstract
Endometriosis is a chronic, estrogen-dependent disease affecting women of reproductive age, associated with chronic pelvic pain, impaired fertility, and significant impairment of quality of life. The heterogeneous clinical presentation, variable disease severity, and high recurrence rates make therapeutic decision-making particularly challenging. This review summarizes and critically compares current evidence regarding four commonly used treatment modalities: the levonorgestrel-releasing intrauterine system (LNG-IUS), relugolix combination therapy, surgical intervention, and dienogest. The analysis focuses on their effectiveness in symptom reduction, safety profile, and suitability for long-term management. A review of randomized controlled trials and meta-analyses demonstrates that all reviewed modalities provide meaningful pain relief, though clinical applicability differs substantially. Surgical treatment, particularly laparoscopic excision, offers rapid symptom improvement, especially in deep infiltrating endometriosis, but is limited by invasiveness and recurrence risk. Dienogest and levonorgestrel-releasing intrauterine system represent minimally invasive hormonal options with sustained analgesic efficacy and favorable safety profiles, making them valuable for long-term disease control and postoperative maintenance. Relugolix combination therapy has emerged as a potent oral treatment for severe symptoms with acceptable long-term safety when combined with add-back therapy, although cost and monitoring requirements may limit its use. No single therapeutic approach can be universally recommended for all patients. Optimal management requires an individualized strategy that balances efficacy, safety, and long-term tolerability. Minimally invasive hormonal therapies offer the most favorable balance for long-term management, while surgery and relugolix therapy remain essential options for selected or refractory cases.Keywords
This publication has 33 references indexed in Scilit:
- Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysisArchives of Gynecology and Obstetrics, 2023
- Oral gonadotropin-releasing hormone antagonists for treating endometriosis-associated pain: a systematic review and network meta-analysisFertility and Sterility, 2022
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgeryCochrane Database of Systematic Reviews, 2021
- Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose–response manner: a randomized, double-blind, placebo-controlled studyFertility and Sterility, 2021
- Correction to: Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practiceArchives of Gynecology and Obstetrics, 2018
- When sex is not on fire: a prospective multicentre study evaluating the short-term effects of radical resection of endometriosis on quality of sex life and dyspareuniaEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2016
- Dienogest in the treatment of endometriosis: systematic reviewArchives of Gynecology and Obstetrics, 2015
- Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatmentEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2014
- Laparoscopic surgery for endometriosis2014
- Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatmentArchives of Gynecology and Obstetrics, 2011